Patient Factors Impacting Adherence to Oral Chemotherapy
Completed
Conditions studied: Breast Cancer, Gastrointestinal Cancer
In brief
The purpose of this study is to identify what makes it easier and what makes it harder to take oral chemotherapy.
Key facts
- Study ID
- NCT01487343
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 79
- Starts
- 2011-11-01
- Expected to finish
- 2016-11-01
- Last updated by the study team
- 2016-11-08
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of primary breast cancer or gastrointestinal cancer
- Currently prescribed capecitabine
- Age 21 years or older
- Able to understand written and oral English
You may not qualify if…
- Major psychopathology or cognitive impairment likely in the judgment of the research staff to interfere with the participation or completion of the protocol.
Where it is running
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.